1
|
Lu X, Cummings C, Osuala UA, Yennawar NH, Namitz KEW, Hellner B, Besada-Lombana PB, Peterson RD, Clark AJ. Characterization of recombinant human lactoferrin expressed in Komagataella phaffii. Analyst 2024; 149:3636-3650. [PMID: 38814097 PMCID: PMC11215759 DOI: 10.1039/d4an00333k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2024]
Abstract
This work presents a thorough characterization of Helaina recombinant human lactoferrin (rhLF, Effera™) expressed in a yeast system at an industrial scale for the first time. Proteomic analysis confirmed that its amino acid sequence is identical to that of native human LF. N-linked glycans were detected at three known glycosylation sites, namely, Asparagines-156, -497, and -642 and they were predominantly oligomannose structures having five to nine mannoses. Helaina rhLF's protein secondary structure was nearly identical to that of human milk lactoferrin (hmLF), as revealed by microfluidic modulation spectroscopy. Results of small-angle X-ray scattering (SAXS) and analytical ultracentrifugation analyses confirmed that, like hmLF, Helaina rhLF displayed well-folded globular structures in solution. Reconstructed solvent envelopes of Helaina rhLF, obtained through the SAXS analysis, demonstrated a remarkable fit with the reported crystalline structure of iron-bound native hmLF. Differential scanning calorimetry investigations into the thermal stability of Helaina rhLF revealed two distinct denaturation temperatures at 68.7 ± 0.9 °C and 91.9 ± 0.5 °C, consistently mirroring denaturation temperatures observed for apo- and holo-hmLF. Overall, Helaina rhLF differed from hmLF in the N-glycans they possessed; nevertheless, the characterization results affirmed that Helaina rhLF was of high purity and exhibited globular structures closely akin to that of hmLF.
Collapse
Affiliation(s)
- Xiaoning Lu
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| | - Chad Cummings
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| | - Udodili A Osuala
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| | - Neela H Yennawar
- X-ray Crystallography Core Facility, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA
| | - Kevin E W Namitz
- X-ray Crystallography Core Facility, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA
| | - Brittney Hellner
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| | | | - Ross D Peterson
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| | - Anthony J Clark
- Helaina Inc., 345 Park Avenue South, 5th Floor, New York, NY 10010, USA.
| |
Collapse
|
2
|
Álvarez-Mayorga BL, Romero-Gómez S, Rosado JL, Ocampo-Hernández J, Gómez-Guzmán J, Ortiz-Frade L. Study of pH and Thermodynamic Parameters via Circular Dichroism Spectroscopy of a Recombinant Human Lactoferrin. Molecules 2024; 29:491. [PMID: 38276569 PMCID: PMC10818261 DOI: 10.3390/molecules29020491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 01/07/2024] [Accepted: 01/09/2024] [Indexed: 01/27/2024] Open
Abstract
The production of human recombinant proteins to be used for therapeutic or nutritional purposes must focus on obtaining a molecule that is as close as possible to the native human protein. This biotechnological tool has been documented in various studies published in recent decades, with lactoferrin being one of those that has generated the most interest, being a promising option for recombinant technology. However, stability studies including thermodynamic parameters have not been reported for recombinant lactoferrin (Lf). The objective of this work was to obtain the human recombinant protein using the yeast Komagataella phaffii to study structural changes modifying pH and temperature using circular dichroism spectroscopy (CD). Thermodynamic parameters such as ΔH, ΔS and Tm were calculated and compared with commercial human lactoferrin. We propose the potential use of CD and thermodynamic parameters as a criterion in the production of recombinant proteins to be used in the production of specialized recombinant proteins.
Collapse
Affiliation(s)
| | - Sergio Romero-Gómez
- Facultad de Química, Universidad Autónoma de Querétaro, Queretaro 76010, Mexico;
| | - Jorge L. Rosado
- Departamento de Nutrición Humana, Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Queretaro 76230, Mexico
| | - Janet Ocampo-Hernández
- Departamento de Electroquímica, Centro de Investigación y Desarrollo Tecnológico en Electroquímica S.C. Parque Tecnológico Querétaro, Sanfandila, Queretaro 76703, Mexico; (J.O.-H.); (J.G.-G.); (L.O.-F.)
| | - J. Gómez-Guzmán
- Departamento de Electroquímica, Centro de Investigación y Desarrollo Tecnológico en Electroquímica S.C. Parque Tecnológico Querétaro, Sanfandila, Queretaro 76703, Mexico; (J.O.-H.); (J.G.-G.); (L.O.-F.)
| | - Luis Ortiz-Frade
- Departamento de Electroquímica, Centro de Investigación y Desarrollo Tecnológico en Electroquímica S.C. Parque Tecnológico Querétaro, Sanfandila, Queretaro 76703, Mexico; (J.O.-H.); (J.G.-G.); (L.O.-F.)
| |
Collapse
|
3
|
Ashraf MF, Zubair D, Bashir MN, Alagawany M, Ahmed S, Shah QA, Buzdar JA, Arain MA. Nutraceutical and Health-Promoting Potential of Lactoferrin, an Iron-Binding Protein in Human and Animal: Current Knowledge. Biol Trace Elem Res 2024; 202:56-72. [PMID: 37059920 PMCID: PMC10104436 DOI: 10.1007/s12011-023-03658-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 04/03/2023] [Indexed: 04/16/2023]
Abstract
Lactoferrin is a natural cationic iron-binding glycoprotein of the transferrin family found in bovine milk and other exocrine secretions, including lacrimal fluid, saliva, and bile. Lactoferrin has been investigated for its numerous powerful influences, including anticancer, anti-inflammatory, anti-oxidant, anti-osteoporotic, antifungal, antibacterial, antiviral, immunomodulatory, hepatoprotective, and other beneficial health effects. Lactoferrin demonstrated several nutraceutical and pharmaceutical potentials and have a significant impact on improving the health of humans and animals. Lactoferrin plays a critical role in keeping the normal physiological homeostasis associated with the development of pathological disorders. The current review highlights the medicinal value, nutraceutical role, therapeutic application, and outstanding favorable health sides of lactoferrin, which would benefit from more exploration of this glycoprotein for the design of effective medicines, drugs, and pharmaceuticals for safeguarding different health issues in animals and humans.
Collapse
Affiliation(s)
| | - Dawood Zubair
- Iqraa Medical Complex, Johar Town Lahore, Punjab, Pakistan
| | | | - Mahmoud Alagawany
- Poultry Department, Agriculture Faculty, Zagazig University, Zagazig, 44519, Egypt.
| | - Shabbir Ahmed
- Faculty of Animal Husbandry & Veterinary Science, Sindh Agriculture University Tandojam, Tandojam, Pakistan
| | - Qurban Ali Shah
- Faculty of Veterinary and Animal Sciences, Lasbela University of Agriculture, Water and Marine Sciences, Uthal, 3800, Balochistan, Pakistan
| | - Jameel Ahmed Buzdar
- Faculty of Veterinary and Animal Sciences, Lasbela University of Agriculture, Water and Marine Sciences, Uthal, 3800, Balochistan, Pakistan
| | - Muhammad Asif Arain
- Faculty of Veterinary and Animal Sciences, Lasbela University of Agriculture, Water and Marine Sciences, Uthal, 3800, Balochistan, Pakistan.
| |
Collapse
|
4
|
Antoshin A, Gostev M, Khristidis Y, Giliazova A, Voloshin S, Blagushina N, Smirnova O, Diachkova E, Istranova E, Usanova A, Solodov N, Fayzullin A, Ivanova E, Sadchikova E, Vergara Bashkatova MN, Drakina O, Tarasenko S, Timashev P. Electrophoretically Co-Deposited Collagen-Lactoferrin Membranes with Enhanced Pro-Regenerative Properties for Oral Soft Tissue Regeneration. Int J Mol Sci 2023; 24:17330. [PMID: 38139159 PMCID: PMC10743871 DOI: 10.3390/ijms242417330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Revised: 12/01/2023] [Accepted: 12/07/2023] [Indexed: 12/24/2023] Open
Abstract
The quality of soft tissue defect regeneration after dental surgeries largely determines their final success. Collagen membranes have been proposed for the healing of such defects, but in some cases, they do not guarantee a sufficient volume of the regenerated tissue and vascularization. For this purpose, lactoferrin, a protein with natural pro-regenerative, anti-inflammatory, and pro-angiogenic activity, can be added to collagen. In this article, we used a semipermeable barrier-assisted electrophoretic deposition (SBA-EPD) method for the production of collagen-lactoferrin membranes. The membrane structure was studied by SEM, and its mechanical properties were shown. The lactoferrin release kinetics were shown by ELISA within 75 h. When tested in vitro, we demonstrated that the collagen-lactoferrin membranes significantly increased the proliferation of keratinocytes (HaCaT) and fibroblasts (977hTERT) compared to blank collagen membranes. In vivo, on the vestibuloplasty and free gingival graft harvesting models, we showed that collagen-lactoferrin membranes decreased the wound inflammation and increased the healing rates and regeneration quality. In some parameters, collagen-lactoferrin membranes outperformed not only blank collagen membranes, but also the commercial membrane Mucograft®. Thus, we proved that collagen-lactoferrin membranes produced by the SBA-EPD method may be a valuable alternative to commercially used membranes for soft tissue regeneration in the oral cavity.
Collapse
Affiliation(s)
- Artem Antoshin
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Mikhail Gostev
- Department of Oral Surgery, Borovskiy Institute of Dentistry, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Yana Khristidis
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Aliia Giliazova
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Sergei Voloshin
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Nataliia Blagushina
- Department of Oral Surgery, Borovskiy Institute of Dentistry, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Olga Smirnova
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Ekaterina Diachkova
- Department of Oral Surgery, Borovskiy Institute of Dentistry, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Elena Istranova
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Anna Usanova
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Nikolai Solodov
- Department of Oral Surgery, Borovskiy Institute of Dentistry, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Alexey Fayzullin
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Elena Ivanova
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Elena Sadchikova
- Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119344 Moscow, Russia
| | | | - Olga Drakina
- Department of Operative Surgery and Topographic Anatomy, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Svetlana Tarasenko
- Department of Oral Surgery, Borovskiy Institute of Dentistry, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| | - Peter Timashev
- Institute for Regenerative Medicine, Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov University, 8-2 Trubetskaya St., 119048 Moscow, Russia
| |
Collapse
|
5
|
Mao R, Ma X, Hao Y, Pen G, Zheng X, Yang N, Teng D, Wang J. Perspective: A proposal on solutions of modern supply chain construction for lactoferrin. J Dairy Sci 2023; 106:7329-7335. [PMID: 37641347 DOI: 10.3168/jds.2023-23328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 06/01/2023] [Indexed: 08/31/2023]
Abstract
Lactoferrin is an iron-binding glycoprotein of the transferrin family that is found in most bodily fluids of mammals and has a variety of biological and beneficial functions, with great importance in health enhancement as a supplement for humans and other animals. More than 300 t of lactoferrin were produced in 2021, and this number is expected to grow yearly by 10% to 12%, to over 580 t in 2030. With new and important functions of lactoferrin being revealed and studied, focus on its industrial production and application is increasing accordingly. However, lactoferrin is mainly sourced from cheese whey or skim milk by cation-exchange column chromatography, which is a costly and low-quality method. A potential solution for lactoferrin global supply chain construction is proposed in this article as a complement to traditional routes of purification from whey or skim milk. The large-scale production of lactoferrin, mainly by recombinant yeast, mammal, and grain systems, as well as the market niche and product design, are discussed.
Collapse
Affiliation(s)
- Ruoyu Mao
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China; R&D Center, Beijing Shengtai Clouds Bio-Technology Inc., Beijing 100081, China
| | - Xuanxuan Ma
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Ya Hao
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China; R&D Center, Beijing Shengtai Clouds Bio-Technology Inc., Beijing 100081, China
| | - Guihong Pen
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Xueling Zheng
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
| | - Na Yang
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China; R&D Center, Beijing Shengtai Clouds Bio-Technology Inc., Beijing 100081, China
| | - Da Teng
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China; R&D Center, Beijing Shengtai Clouds Bio-Technology Inc., Beijing 100081, China
| | - Jianhua Wang
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China; Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China; R&D Center, Beijing Shengtai Clouds Bio-Technology Inc., Beijing 100081, China.
| |
Collapse
|
6
|
Li W, Liu B, Lin Y, Xue P, Lu Y, Song S, Li Y, Szeto IMY, Ren F, Guo H. The application of lactoferrin in infant formula: The past, present and future. Crit Rev Food Sci Nutr 2022; 64:5748-5767. [PMID: 36533432 DOI: 10.1080/10408398.2022.2157792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Human milk is universally regarded as the gold standard to fulfill nutrition needs of infants. Lactoferrin (LF) is a major multiple bioactive glycoprotein in human milk but little is presented in infant formula. LF can resist digestion in the infant gastrointestinal tract and is absorbed into the bloodstream in an intact form to perform physiological functions. Evidence suggest that LF prevents pathogen infection, promotes immune system development, intestinal development, brain development and bone health, as well as ameliorates iron deficiency anemia. However, more clinical studies of LF need to be further elucidated to determine an appropriate dosage for application in infant formula. LF is sensitive to denaturation induced by processing of infant formula such as heat treatments and spay drying. Thus, further studies should be focus on maximizing the retention of LF activity in the infant formula process. This review summarizes the structural features of LF. Then the digestion, absorption and metabolism of LF in infants are discussed, followed by the function of LF for infants. Further, we summarize LF in infant formula and effects of processing of infant formula on bioactivities of LF, as well as future perspectives of LF research.
Collapse
Affiliation(s)
- Wusun Li
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
| | - Biao Liu
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
- Inner Mongolia Yili Industrial Group Co., Ltd, Hohhot, PR China
| | - Yingying Lin
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
- Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing, PR China
| | - Peng Xue
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
| | - Yao Lu
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
| | - Sijia Song
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
| | - Yixuan Li
- Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing, PR China
| | - Ignatius Man-Yau Szeto
- Inner Mongolia Yili Industrial Group Co., Ltd, Hohhot, PR China
- National Center of Technology Innovation for Dairy, Hohhot, PR China
| | - Fazheng Ren
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
- Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing, PR China
| | - Huiyuan Guo
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, PR China
- Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing, PR China
| |
Collapse
|
7
|
Nopia H, Kurimoto D, Sato A. Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration. Biometals 2022; 36:629-638. [PMID: 36167912 DOI: 10.1007/s10534-022-00447-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 09/14/2022] [Indexed: 11/30/2022]
Abstract
The fusion of human serum albumin (HSA) with human lactoferrin (hLF) (designated as hLF-HSA) has improved the pharmacokinetic properties and anti-proliferative activities of hLF against cancer cells. In this study, we evaluated the anti-migratory activities of hLF and hLF-HSA against the human lung adenocarcinoma PC-14 cell line using wound healing and Boyden chamber assays. Despite the unexpected hLF-induced migration, hLF-HSA clearly demonstrated the complete inhibition of PC-14 cell migration. To examine the mechanism underlying the enhanced PC-14 cell migration by hLF alone but suppressed migration by hLF-HSA, we focused on the matrix metalloproteinase (MMP) family of endopeptidases because MMPs are often reported to play important roles in facilitating the migration and metastasis of cancer cells. Furthermore, hLF is a transactivator of MMP1 transcription. As expected, treatment of cells with hLF and hLF-HSA led to the upregulation and downregulation of MMP1, respectively. In contrast, MMP9 expression levels, which are often associated with cancer migration, were unchanged in the presence of either protein. An MMP inhibitor attenuated hLF-induced migration of PC-14 cells. Therefore, specific enhancement and suppression of MMP1 expression by hLF and hLF-HSA have been implicated as causes of a marked increase and decrease in PC-14 cell migration, respectively. In conclusion, the fusion of HSA with hLF (hLF-HSA) promoted its anti-migratory effects against cancer cells. Therefore, hLF-HSA is a promising anti-cancer drug candidate based on its improved anti-migratory activity towards cancer cells.
Collapse
Affiliation(s)
- Hana Nopia
- School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, 192-0982, Tokyo, Japan
| | - Daisuke Kurimoto
- School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, 192-0982, Tokyo, Japan
| | - Atsushi Sato
- School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, 192-0982, Tokyo, Japan.
| |
Collapse
|
8
|
Leonova EI, Reshetnikov VV, Sopova JV. CRISPR/Cas-edited pigs for personalized medicine: more than preclinical test-system. RESEARCH RESULTS IN PHARMACOLOGY 2022. [DOI: 10.3897/rrpharmacology.8.83872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Novel CRISPR-Cas-based genome editing tools made it feasible to introduce a variety of precise genomic modifications in the pig genome, including introducing multiple edits simultaneously, inserting long DNA sequences into specifically targeted loci, and performing nucleotide transitions and transversions. Pigs serve as a vital agricultural resource and animal model in biomedical studies, given their advantages over the other models. Pigs share high similarities to humans regarding body/organ size, anatomy, physiology, and a metabolic profile. The pig genome can be modified to carry the same genetic mutations found in humans to replicate inherited diseases to provide preclinical trials of drugs. Moreover, CRISPR-based modification of pigs antigen profile makes it possible to offer porcine organs for xenotransplantation with minimal transplant rejection responses. This review summarizes recent advances in endonuclease-mediated genome editing tools and research progress of genome-edited pigs as personalized test-systems for preclinical trials and as donors of organs with human-fit antigen profile.
Graphical abstract:
Collapse
|
9
|
Rudnichenko YA, Novakovskaya SA, Lukashevich VS. Long-Term Intake of Recombinant Human Lactoferrin Corrects Changes in Serum Biochemical Parameters and Liver Injuries Induced by Chronic Alcohol Intoxication in Rats. J EVOL BIOCHEM PHYS+ 2022. [DOI: 10.1134/s0022093022020144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
10
|
Deykin AV, Shcheblykina OV, Povetka EE, Golubinskaya PA, Pokrovsky VM, Korokina LV, Vanchenko OA, Kuzubova EV, Trunov KS, Vasyutkin VV, Radchenko AI, Danilenko AP, Stepenko JV, Kochkarova IS, Belyaeva VS, Yakushev VI. Genetically modified animals for use in biopharmacology: from research to production. RESEARCH RESULTS IN PHARMACOLOGY 2021. [DOI: 10.3897/rrpharmacology.7.76685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Introduction: In this review, the analysis of technologies for obtaining biologically active proteins from various sources is carried out, and the comparative analysis of technologies for creating producers of biologically active proteins is presented. Special attention is paid to genetically modified animals as bioreactors for the pharmaceutical industry of a new type. The necessity of improving the technology of development transgenic rabbit producers and creating a platform solution for the production of biological products is substantiated.
The advantages of using TrB for the production of recombinant proteins: The main advantages of using TrB are the low cost of obtaining valuable complex therapeutic human proteins in readily accessible fluids, their greater safety relative to proteins isolated directly from human blood, and the greater safety of the activity of the native protein.
The advantages of the mammary gland as a system for the expression of recombinant proteins: The mammary gland is the organ of choice for the expression of valuable recombinant proteins because milk is easy to collect in large volumes.
Methods for obtaining transgenic animals: The modern understanding of the regulation of gene expression and the discovery of new tools for gene editing can increase the efficiency of creating bioreactors for animals and help to obtain high concentrations of the target protein.
The advantages of using rabbits as bioreactors producing recombinant proteins in milk: The rabbit is a relatively small animal with a short duration of gestation, puberty and optimal size, capable of producing up to 5 liters of milk per year per female, receiving up to 300 grams of the target protein.
Collapse
|
11
|
Gong G, Zhang W, Xie L, Xu L, Han S, Hu Y. Expression of a recombinant anti-programed cell death 1 antibody in the mammary gland of transgenic mice. Prep Biochem Biotechnol 2020; 51:183-190. [PMID: 32808868 DOI: 10.1080/10826068.2020.1805755] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Nivolumab, a fully human IgG4 anti-programed cell death 1(PD-1)antibody, is recently one of the most popular and successful therapeutic monoclonal antibodies in clinical use. With the increasing demands for Nivolumab and other therapeutic monoclonal antibodies, the mammary gland bioreactor has been regarded as another choice for the production of recombinant monoclonal antibodies besides mammalian cell culture. Here, we expressed a recombinant human anti-PD-1 antibody in the mammary glands of transgenic mice. Two expression vectors were constructed bearing the heavy and light chains of anti-PD-1 antibody respectively under the control of bovine αs1-casein promoter. Transgenic mice were then generated by co-microinjection of the two expression cassettes. Three F0 founders with both heavy chain and light chain positive were obtained. Transgenes of both chains were detected to be stably transmitted to the offspring. The recombinant antibody was detected in the milk of transgenic mice with the highest expression level up to 80.52 ± 0.82 mg/L and could specifically binds to the human PD-1 antigen. Therefore, our results suggest the feasibility of anti-PD-1 antibody production in the milk of transgenic animals.
Collapse
Affiliation(s)
- Guihua Gong
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| | - Wei Zhang
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| | - Liping Xie
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| | - Lei Xu
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| | - Shu Han
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| | - Youjia Hu
- China State Institute of Pharmaceutical Industry, Shanghai, P. R. China
| |
Collapse
|
12
|
Semak I, Budzevich A, Maliushkova E, Kuzniatsova V, Popkov N, Zalutsky I, Ivashkevich O. Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin. Transgenic Res 2019; 28:465-478. [PMID: 31396786 DOI: 10.1007/s11248-019-00165-y] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 07/31/2019] [Indexed: 12/16/2022]
Abstract
The primary male-goats Lac-1 (human lactoferrin gene construct hLF5) and Lac-2 (human lactoferrin gene construct hLF3) with genome containing human lactoferrin gene were bred and the sperm bank of primary male-goats and their male descendents (F1-F7) was created. The herd of goats (200 transgenic females) that produced recombinant human lactoferrin (rhLF) in their milk at levels up to 16 g/L was obtained. The rhLF from milk of transgenic goats, natural human lactoferrin (hLF) from woman milk and natural goat lactoferrin (gLF) from milk of non-transgenic goats were purified using cation-exchange chromatography. It has been shown that rhLF is a glycoprotein and its physicochemical characteristics of rhLF are similar to hLf as revealed by different analytical methods including electron paramagnetic resonance, spectrophotometry, differential scanning calorimetry, mass spectrometry and peptide mapping. The high expression level of rhLF achieved in milk of transgenic goats provides a solid basis for developing an efficient and cost-effective downstream processing. The rhLF exhibited a prominent biological activity suggesting it as a promising biopharmaceutical and food supplements.
Collapse
Affiliation(s)
- I Semak
- Belarusian State University, Nezavisimosti Avenue 4, 220030, Minsk, Belarus.
| | - A Budzevich
- Scientific and Practical Centre on Animal Husbandry of the National Academy of Sciences of Belarus, 11 Frunze Str., 222160, Zhodino, Belarus
| | - E Maliushkova
- Belarusian State University, Nezavisimosti Avenue 4, 220030, Minsk, Belarus
| | - V Kuzniatsova
- Scientific and Practical Centre on Animal Husbandry of the National Academy of Sciences of Belarus, 11 Frunze Str., 222160, Zhodino, Belarus
| | - N Popkov
- Scientific and Practical Centre on Animal Husbandry of the National Academy of Sciences of Belarus, 11 Frunze Str., 222160, Zhodino, Belarus
| | - I Zalutsky
- Institute of Physiology of the National Academy of Sciences of Belarus, 28 Academicheskaya Str., 220072, Minsk, Belarus
| | - O Ivashkevich
- Belarusian State University, Nezavisimosti Avenue 4, 220030, Minsk, Belarus
| |
Collapse
|
13
|
Kalmykov VA, Kusov PA, Deykin AV. Development of a Multiplex PCR Test System for the Determination of a Transgene Based on the pBC1 Plasmid and Its Derivatives for the Expression of Recombinant Proteins in Mus musculus Milk. DOKL BIOCHEM BIOPHYS 2019; 485:153-156. [PMID: 31201639 DOI: 10.1134/s1607672919020212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Indexed: 11/23/2022]
Abstract
A multiplex PCR test system for identification of the regulatory sequences of genetic constructs for transformation (promotor, insulator, and terminator) in the Mus musculus genome and for transgenic animal selection by genotyping with horizontal agarose gel electrophoresis detection was developed. The proposed system was validated by genotyping mouse strains producing human lactoferrin, heat shock protein HSP 70, firefly luciferase, and lysozyme, which were obtained by microinjections of linearized DNA into murine zygote pronucleus with random transgene integration into the genome using the pBC1 plasmid for expression of the gene of interest in milk of transformed animals (milk expression vector kit).
Collapse
Affiliation(s)
- V A Kalmykov
- Institute of Gene Biology, Russian Academy of Sciences, 119334, Moscow, Russia
| | - P A Kusov
- Institute of Gene Biology, Russian Academy of Sciences, 119334, Moscow, Russia.,Skolkovo Institute of Science and Technology, 143025, Skolkovo, Moscow oblast, Russia
| | - A V Deykin
- Institute of Gene Biology, Russian Academy of Sciences, 119334, Moscow, Russia. .,Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, 125315, Moscow, Russia.
| |
Collapse
|
14
|
Transcription termination sequences support the expression of transgene product secreted with milk. Transgenic Res 2019; 28:401-410. [PMID: 30919251 DOI: 10.1007/s11248-019-00122-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Accepted: 03/12/2019] [Indexed: 01/04/2023]
Abstract
Expression of the reporter gene in transgenic animals depends on the surrounding chromatin environment. Recent genome-wide studies have shown that, in mammals, the entire genome is transcribed. Transcription through a transgene often has a negative effect on the expression of a reporter gene. Here, we compared the ability of well-studied chicken chromatin insulator HS4 and bidirectional transcription terminators from the human genome to support high-level expression of the firefly luciferase gene (Fluc) under control of the previously characterized goat β-casein gene promoter. The insertion of HS4 or either of the two transcription terminators upstream of the promoter resulted in tenfold enhancement of Fluc expression in the mammary glands of transgenic mice. These results suggest that transcriptional terminators, similar to the HS4 insulator, can be used to improve the reporter gene expression in transgenic animals.
Collapse
|
15
|
Silaeva YY, Kirikovich YK, Skuratovskaya LN, Deikin AV. Optimal Number of Embryos for Transplantation in Obtaining Genetic-Modified Mice and Goats. Russ J Dev Biol 2019. [DOI: 10.1134/s106236041806005x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
16
|
He Z, Jiang L, Zhang T, Zhou M, Wu D, Yuan T, Yuan Y, Cheng Y. Efficient increase of the novel recombinant human plasminogen activator expression level and stability through the use of homozygote transgenic rabbits. Int J Mol Med 2018; 42:2269-2275. [PMID: 30015826 DOI: 10.3892/ijmm.2018.3754] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Accepted: 06/19/2018] [Indexed: 11/05/2022] Open
Abstract
Expression efficacy of recombinant protein in current expression systems is generally low. Therefore, the expression levels of recombinant proteins in the breast milk of transgenic animals are typically low. In view of this, the present study aimed to construct homozygous transgenic rabbits with a high expression level of recombinant human plasminogen activator (rhPA) during the entire lactation period. Homozygous transgenic rabbits were obtained using an effective rhPA mammary‑specific expression vector PCL25/rhPA. The expression level and thrombolytic ability of rhPA in the milk of both homozygous and hemizygous rabbits were detected by enzyme‑linked immunosorbent and fibrin agarose plate assays. It was observed that the expression of rhPA was constant during the entire lactation period in homozygous rabbits, while the expression of rhPA declined slowly in hemizygote rhPA transgenic rabbits during the lactation period. In addition, the expression of rhPA in homozygous transgenic rabbit was ~950 µg/ml, which was markedly higher in comparison with that in hemizygote rabbits. Furthermore, increased gene copy number was observed to increase the expression level of rhPA at the same integration vector.
Collapse
Affiliation(s)
- Zhengyi He
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Lei Jiang
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Ting Zhang
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Minya Zhou
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Daijin Wu
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Tingting Yuan
- Medical College of Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Yuguo Yuan
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| | - Yong Cheng
- College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
| |
Collapse
|
17
|
Rudnichenko YA, Lukashevich VS, Zalutsky IV. [Experimental study of the influence of recombinant human lactoferrin on the levels of androgens and basic parameters of lipid and protein metabolism]. BIOMEDIT︠S︡INSKAI︠A︡ KHIMII︠A︡ 2017; 62:566-571. [PMID: 27797332 DOI: 10.18097/pbmc20166205566] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
System administration of human recombinant lactoferrin per os to rats for 2,5 months increased serum and testicular levels of total testosterone. The data correlated with the increase in free testosterone levels. These changes were accompanied by an increase of concentrations of steroidogenesis substrates (cholesterol, progesterone, and 17-OH progesterone) and a decrease of the estradiol content in blood serum. This resulted in the 3.6-3.8-fold increase of the testosterone/estradiol index. Basic parameters of lipid and protein were also studied. Results of this study suggest that lactoferrin administration causes activation of androgen synthesis and lipid metabolism.
Collapse
Affiliation(s)
- Yu A Rudnichenko
- Institute of Physiology, National Academy of Sciences of Belarus, Minsk, Belarus
| | - V S Lukashevich
- Institute of Physiology, National Academy of Sciences of Belarus, Minsk, Belarus
| | - I V Zalutsky
- Institute of Physiology, National Academy of Sciences of Belarus, Minsk, Belarus
| |
Collapse
|
18
|
Kaiser GG, Mucci NC, González V, Sánchez L, Parrón JA, Pérez MD, Calvo M, Aller JF, Hozbor FA, Mutto AA. Detection of recombinant human lactoferrin and lysozyme produced in a bitransgenic cow. J Dairy Sci 2017; 100:1605-1617. [PMID: 28109583 DOI: 10.3168/jds.2016-11173] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2016] [Accepted: 10/07/2016] [Indexed: 02/02/2023]
Abstract
Lactoferrin and lysozyme are 2 glycoproteins with great antimicrobial activity, being part of the nonspecific defensive system of human milk, though their use in commercial products is difficult because human milk is a limited source. Therefore, many investigations have been carried out to produce those proteins in biological systems, such as bacteria, yeasts, or plants. Mammals seem to be more suitable as expression systems for human proteins, however, especially for those that are glycosylated. In the present study, we developed a bicistronic commercial vector containing a goat β-casein promoter and an internal ribosome entry site fragment between the human lactoferrin and human lysozyme genes to allow the introduction of both genes into bovine adult fibroblasts in a single transfection. Embryos were obtained by somatic cell nuclear transfer, and, after 6 transferences to recipients, 3 pregnancies and 1 viable bitransgenic calf were obtained. The presence of the vector was confirmed by fluorescent in situ hybridization of skin cells. At 13 mo of life and after artificial induction of lactation, both recombinant proteins were found in the colostrum and milk of the bitransgenic calf. Human lactoferrin concentration in the colostrum was 0.0098 mg/mL and that in milk was 0.011 mg/mL; human lysozyme concentration in the colostrum was 0.0022 mg/mL and that in milk was 0.0024 mg/mL. The molar concentration of both human proteins revealed no differences in protein production of the internal ribosome entry site upstream and downstream protein. The enzymatic activity of lysozyme in the transgenic milk was comparable to that of human milk, being 6 and 10 times higher than that of bovine lysozyme present in milk. This work represents an important step to obtain multiple proteins or enhance single protein production by using animal pharming and fewer regulatory and antibiotic-resistant foreign sequences, allowing the design of humanized milk with added biological value for newborn nutrition and development. Transgenic animals can offer a unique opportunity to the dairy industry, providing starting materials suitable to develop specific products with high added value.
Collapse
Affiliation(s)
- Germán G Kaiser
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina.
| | - Nicolás C Mucci
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Vega González
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Lourdes Sánchez
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - José A Parrón
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - María D Pérez
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Miguel Calvo
- Tecnología de los Alimentos, Facultad de Veterinaria, Universidad de Zaragoza, 50013 Zaragoza, Spain
| | - Juan F Aller
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Federico A Hozbor
- Grupo de Biotecnología de la Reproducción, Instituto Nacional de Tecnología Agropecuaria, 7620 Balcarce, Argentina
| | - Adrián A Mutto
- Laboratorio Biotecnologías Aplicadas a la Reproducción y Mejoramiento Genético Animal, Instituto de Investigaciones Biotechnològicas-Instituto Tecnològico Chascomùs (IIB-INTECH), Universidad Nacional de San Martin-Consejo de Investigaciones Cientìficas y Tècnicas (CONICET), 1650 San Martin, Argentina
| |
Collapse
|
19
|
Donovan SM. The Role of Lactoferrin in Gastrointestinal and Immune Development and Function: A Preclinical Perspective. J Pediatr 2016; 173 Suppl:S16-28. [PMID: 27234407 DOI: 10.1016/j.jpeds.2016.02.072] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The early postnatal period is a critical time for gastrointestinal (GI) and immune development. Neonates fed mother's milk have more rapid GI and immune development than fed-formula infants. In addition, clinical and epidemiologic data provide strong evidence that breastfeeding reduces the incidence and/or severity of infectious diseases. Lactoferrin is a 77 kDa, iron-binding glycoprotein that is present at high concentration in human milk compared with bovine milk and infant formula. It is a multifunctional protein that mediates many of the physiological processes in which breastfed infants have advantages over their formula-fed peers, including promoting GI and immune development, protection from infections, and improved cognitive development. Feeding bovine lactoferrin or recombinant human lactoferrin was well tolerated and stimulated intestinal cell proliferation and increased villus length and crypt depth in piglets. Lactoferrin also influenced both systemic and GI immune development by stimulating a balanced T-helper-1/T-helper-2 cytokine immune response. Further, there was a tendency for immune cells to secrete more anti-inflammatory cytokines in an unstimulated state, while being primed for a robust pro-inflammatory response when presented with a bacterial trigger in piglets fed lactoferrin. These findings support clinical studies demonstrating benefits of dietary lactoferrin in the prevention of infections, late onset sepsis, and necrotizing enterocolitis.
Collapse
Affiliation(s)
- Sharon M Donovan
- Department of Food Science and Human Nutrition, University of Illinois, Urbana, IL.
| |
Collapse
|
20
|
Mukherjee A, Garrels W, Talluri TR, Tiedemann D, Bősze Z, Ivics Z, Kues WA. Expression of Active Fluorophore Proteins in the Milk of Transgenic Pigs Bypassing the Secretory Pathway. Sci Rep 2016; 6:24464. [PMID: 27086548 PMCID: PMC4834472 DOI: 10.1038/srep24464] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2015] [Accepted: 03/30/2016] [Indexed: 12/12/2022] Open
Abstract
We describe the expression of recombinant fluorescent proteins in the milk of two lines of transgenic pigs generated by Sleeping Beauty transposon-mediated genetic engineering. The Sleeping Beauty transposon consisted of an ubiquitously active CAGGS promoter driving a fluorophore cDNA, encoding either Venus or mCherry. Importantly, the fluorophore cDNAs did not encode for a signal peptide for the secretory pathway, and in previous studies of the transgenic animals a cytoplasmic localization of the fluorophore proteins was found. Unexpectedly, milk samples from lactating sows contained high levels of bioactive Venus or mCherry fluorophores. A detailed analysis suggested that exfoliated cells of the mammary epithelium carried the recombinant proteins passively into the milk. This is the first description of reporter fluorophore expression in the milk of livestock, and the findings may contribute to the development of an alternative concept for the production of bioactive recombinant proteins in the udder.
Collapse
Affiliation(s)
- Ayan Mukherjee
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| | - Wiebke Garrels
- Medical School Hannover, Institute of Laboratory Animal Sciences, Hannover, Germany
| | | | - Daniela Tiedemann
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| | - Zsuzsanna Bősze
- NARIC- Agricultural Biotechnology Institute, Gödöllö, Hungary
| | | | - Wilfried A. Kues
- Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Mariensee, Germany
| |
Collapse
|
21
|
Cooper CA, Maga EA, Murray JD. Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future. Transgenic Res 2015; 24:605-14. [PMID: 26059245 DOI: 10.1007/s11248-015-9885-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Accepted: 06/03/2015] [Indexed: 12/29/2022]
Abstract
Genetic engineering, which was first developed in the 1980s, allows for specific additions to animals' genomes that are not possible through conventional breeding. Using genetic engineering to improve agricultural animals was first suggested when the technology was in the early stages of development by Palmiter et al. (Nature 300:611-615, 1982). One of the first agricultural applications identified was generating transgenic dairy animals that could produce altered or novel proteins in their milk. Human milk contains high levels of antimicrobial proteins that are found in low concentrations in the milk of ruminants, including the antimicrobial proteins lactoferrin and lysozyme. Lactoferrin and lysozyme are both part of the innate immune system and are secreted in tears, mucus, and throughout the gastrointestinal (GI) tract. Due to their antimicrobial properties and abundance in human milk, multiple lines of transgenic dairy animals that produce either human lactoferrin or human lysozyme have been developed. The focus of this review is to catalogue the different lines of genetically engineered dairy animals that produce either recombinant lactoferrin or lysozyme that have been generated over the years as well as compare the wealth of research that has been done on the in vitro and in vivo effects of the milk they produce. While recent advances including the development of CRISPRs and TALENs have removed many of the technical barriers to predictable and efficient genetic engineering in agricultural species, there are still many political and regulatory hurdles before genetic engineering can be used in agriculture. It is important to consider the substantial amount of work that has been done thus far on well established lines of genetically engineered animals evaluating both the animals themselves and the products they yield to identify the most effective path forward for future research and acceptance of this technology.
Collapse
Affiliation(s)
- Caitlin A Cooper
- Department of Animal Science, University of California-Davis, 1 Shields Ave, Davis, CA, USA,
| | | | | |
Collapse
|
22
|
Tillib SV, Privezentseva ME, Ivanova TI, Vasilev LF, Efimov GA, Gursky YG, Georgiev GP, Goldman IL, Sadchikova ER. Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 949-950:48-57. [PMID: 24463400 DOI: 10.1016/j.jchromb.2013.12.034] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Revised: 12/23/2013] [Accepted: 12/26/2013] [Indexed: 11/18/2022]
Abstract
Single-domain antibody generation technology was applied to make new Sepharose-bound ligands for affinity separation of closely related proteins, such as human and goat lactoferrin. We generated recombinant antibodies that can selectively bind/recognize only lactoferrins having amino acid sequences identical to that of human natural lactoferrin (anti-hLF Ab). Selected and purified histidine-tagged single-domain antibodies were used as ligands, and different lactoferrins were used as analytes in the kinetics analysis of lactoferrin binding to captured anti-hLF Abs using the Bio-Rad ProteOn XPR36 protein interaction array system. The data obtained were consistent with a 1:1 binding model with very high affinity, practically equal in the case of hLF and rec-hLF (calculated KD varied from 0.43nM to 3.7nM). Interaction of captured fsdAbs with goat LF was significantly weaker and not detectable under the same analysis conditions. We demonstrated the high efficiency of the recombinant human lactoferrin purification from goat lactoferrin and other proteins using the obtained single domain antibody-based affinity ligands. We believe this approach can be used for the generation of single-domain antibody-based affinity media for the efficient separation/purification of a wide spectrum of other highly homologous proteins.
Collapse
Affiliation(s)
- S V Tillib
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
| | - M E Privezentseva
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - T I Ivanova
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - L F Vasilev
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - G A Efimov
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
| | - Y G Gursky
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - G P Georgiev
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - I L Goldman
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| | - E R Sadchikova
- Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
| |
Collapse
|
23
|
Khodarovich YM, Goldman IL, Sadchikova ER, Georgiev PG. Expression of eukaryotic recombinant proteins and deriving them from the milk of transgenic animals. APPL BIOCHEM MICRO+ 2013. [DOI: 10.1134/s0003683813090020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|